Cancer screening in the United States, 2007: A review of current guidelines, practices, and prospects

CA Cancer Journal for Clinicians

Volumn 57, Issue 2, 2007, Pages 90-104

  Smith, Robert A ^a   Cokkinides, Vilma ^a   Eyre, Harmon J ^a  

^a AMERICAN CANCER SOCIETY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOMATOUS POLYP; CANCER CONTROL; CANCER DIAGNOSIS; CANCER SCREENING; CLINICAL PRACTICE; COLORECTAL CANCER; DISEASE SURVEILLANCE; ETHNICITY; HEALTH INSURANCE; HEALTH SURVEY; HUMAN; LUNG CANCER; MEDICAL LITERATURE; MEDICAL SOCIETY; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; PROSTATE CANCER; RACE DIFFERENCE; REVIEW;

ADOLESCENT; ADULT; AMERICAN CANCER SOCIETY; BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM; BREAST NEOPLASMS; COLORECTAL NEOPLASMS; CONTINENTAL POPULATION GROUPS; ENDOMETRIAL NEOPLASMS; ETHNIC GROUPS; FEMALE; GUIDELINES; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASMS; PHYSICIAN'S PRACTICE PATTERNS; PROSTATIC NEOPLASMS; RISK FACTORS; UNITED STATES; UTERINE CERVICAL NEOPLASMS;

EID: 34047233628     PISSN: 00079235     EISSN: 15424863     Source Type: Journal    
DOI: 10.3322/canjclin.57.2.90     Document Type: Review

References (61)

1. Smith RA, Mettlin CJ, Davis KJ, Eyre H. American Cancer Society guidelines for the early detection of cancer. CA Cancer J Clin 2000;50:34-49.
2. Smith RA, Saslow D, Sawyer KA, et al. American Cancer Society guidelines for breast cancer screening: update 2003. CA Cancer J Clin 2003;53:141-169.
3. Saslow D, Boetes C, Burke W, et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 2007;57:75-89.
4. Saslow D, Runowicz CD, Solomon D, et al. American Cancer Society guideline for the early detection of cervical neoplasia and cancer. CA Cancer J Clin 2002;52:342-362.
5. Saslow D, Castle PE, Cox JT, et al. American Cancer Society guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors. CA Cancer J Clin 2007;57:7-28.
6. Smith RA, von Eschenbach AC, Wender R, et al. American Cancer Society guidelines for the early detection of cancer: update of early detection guidelines for prostate, colorectal, and endometrial cancers. Also: update 2001 - testing for early lung cancer detection. CA Cancer J Clin 2001;51:38-75.
7. Levin B, Brooks D, Smith RA, Stone A. Emerging technologies in screening for colorectal cancer: CT colonography, immunochemical fecal occult blood tests, and stool screening using molecular markers. CA Cancer J Clin 2003;53:44-55.
8. Rex DK, Kahi CJ, Levin B, et al. Guidelines for colonoscopy surveillance after cancer resection: a consensus update by the American Cancer Society and the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology 2006;130:1865-1871.
9. Winawer SJ, Zauber AG, Fletcher RH, et al. Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. CA Cancer J Clin 2006;56:143-159.
10. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2007. CA Cancer J Clin 2007;57:43-66.
11. Walter LC, Covinsky KE. Cancer screening in elderly patients: a framework for individualized decision making. JAMA 2001;285:2750-2756.
12. Franco EL, Schlecht NF, Saslow D. The epidemiology of cervical cancer. Cancer J 2003;9:348-359.
13. USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: a summary. MMWR Recomm Rep 1995;44:1-34.
14. Mysliwiec PA, Brown ML, Klabunde CN, Ransohoff DF. Are physicians doing too much colonoscopy? A national survey of colorectal surveillance after polypectomy. Ann Intern Med 2004;141:264-271.
15. Ko CW, Riffle S, Shapiro JA, et al. Incidence of minor complications and time lost from normal activities after screening or surveillance colonoscopy. Gastrointest Endosc 2006 Dec 13; [Epub ahead of print].
16. Collins JF, Lieberman DA, Durbin TE, Weiss DG, and the Veterans Affairs Cooperative Study #380 Group. Accuracy of screening for fecal occult blood on a single stool sample obtained by digital rectal examination: a comparison with recommended sampling practice. Ann Intern Med 2005;142:81-85.
17. Winawer S, Fletcher R, Rex D, et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale - Update based on new evidence. Gastroenterology 2003;124:544-560.
18. Walker JL, Nunez ER. Endometrial Cancer, in Kramer BS, Gohagan JK, Prorok PC (eds). Cancer Screening: Theory and Practice. New York, NY: Marcel Dekker, Inc.; 1999:531-566.
19. Eddy D. Guidelines for the cancer related checkup: Recommendations and rationale. CA Cancer J Clin 1980;30:194-240.
20. Henschke CI, McCauley DI, Yankelevitz DF, et al. Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet 1999;354:99-105.
21. Pastorino U, Bellomi M, Landoni C, et al. Early lung-cancer detection with spiral CT and positron emission tomography in heavy smokers: 2-year results. Lancet 2003;362:593-597.
22. Ford LG, Minasian LM, McCaskill-Stevens W, et al. Prevention and early detection clinical trials: opportunities for primary care providers and their patients. CA Cancer J Clin 2003;53:82-101.
23. International Early Lung Cancer Action Program Investigators, and Henschke CI, Yankelevitz DF, Libby DM, et al. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med 2006;355:1763-1771.
24. Maciosek MV, Coffield AB, Edwards NM, et al. Priorities among effective clinical preventive services: results of a systematic review and analysis. Am J Prev Med 2006;31:52-61.
25. Coffield AB, Maciosek MV, McGinnis JM, et al. Priorities among recommended clinical preventive services. Am J Prev Med 2001;21:1-9.
26. U.S. Preventive Services Task Force. Guide to Clinical Preventive Services. 3rd ed. Periodic Update. Washington, DC: Agency for Healthcare Research. and Quality; 2004.
27. Health, United States, 2005 with Chartbook on Trends in the Health of Americans. Hyattsville, MD: National Center for Health Statistics; 2005.
28. Design and estimation for the National Health Interview Survey, 1995-2004. Vital Health Stat 2 2000;130:1-31.
29. Hiatt RA, Klabunde C, Breen N, et al. Cancer screening practices from National Health Interview Surveys: past, present, and future. J Natl Cancer Inst 2002;94:1837-1846.
30. National Center for Health Statistics, Centers for Disease Control and Prevention. National Health Interview Survey. Available at: http://www.cdc.gov/ nchs/nhis.htm. Accessed June 15, 2006.
31. Lieberman DA, Weiss DG, and the Veterans Affairs Cooperative Study Group 380. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon. N Engl J Med 2001;345:555-560.
32. Nadel MR, Shapiro JA, Klabunde CN, et al. A national survey of primary care physicians' methods for screening for fecal occult blood. Ann Intern Med 2005;142:86-94.
33. Centers for Disease Control and Prevention. Behavioral Risk Factor Surveillance System Public Use Data Tape 2004. Atlanta, GA: National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention; 2005.
34. Research Triangle Institute. SUDAAN: Professional software for survey data analysis: user documentation for Release 9.0. Research Triangle Park, NC: Research Triangle Institute; 2004.
35. Ross LE, Coates RJ, Breen N, et al. Prostate-specific antigen test use reported in the 2000 National Health Interview Survey. Prev Med 2004;38:732-744.
36. Meissner H, Breen N, Klabunde C, Vernon S. Patterns of colorectal cancer screening uptake among men and women in the United States. Cancer Epidemiol Biomarkers Prev 2006;15:389-394.
37. Cram P, Fendrick A, Inadomi J, et al. The impact of a celebrity promotional campaign on the use of colon cancer screening: the Katie Couric effect. Arch Intern Med 2003;163:1601-1605.
38. Saraiya M, Hall HI, Thompson T, et al. Skin cancer screening among U.S. adults from 1992, 1998, and 2000 National Health Interview Surveys. Prev Med 2004;39:308-314.
39. Cooper GS, Koroukian SM. Geographic variation among Medicare beneficiaries in the use of colorectal carcinoma screening procedures. Am J Gastroenterol 2004;99:1544-1550.
40. Lawson HW, Henson R, Bobo JK, Kaeser MK. Implementing recommendations for the early detection of breast and cervical cancer among low-income women. MMWR Recomm Rep 2000;49:37-55.
41. Centers for Disease Control and Prevention. National Breast and Cervical Cancer Early Detection Program Fact Sheet 2004/2005. Atlanta, GA: Centers for Disease Control and Prevention; 2005.
42. Smith RA, Cokkinides V, Eyre HJ. American Cancer Society guidelines for the early detection of cancer, 2005. CA Cancer J Clin 2005;55:31-44.
43. Howe HL, Wu X, Ries LA, et al. Annual report to the nation on the status of cancer, 1975-2003, featuring cancer among U.S. Hispanic/Latino populations. Cancer 2006;107:1711-1742.
44. Ravdin P, Cronin K, Howlander N, et al. A Sharp Decrease in Breast Cancer Incidence in the United States in 2003. Paper presented at: 2006 Annual San Antonio Breast Cancer Symposium (SABCS); December 14, 2006; San Antonio, Texas. Abstract 5.
45. Farria DM, Schmidt ME, Monsees BS, et al. Professional and economic factors affecting access to mammography: a crisis today, or tomorrow? Results from a national survey. Cancer 2005;104:491-498.
46. Smith RA, Cokkinides V, Eyre HJ. American Cancer Society guidelines for the early detection of cancer, 2006. CA Cancer J Clin 2006;56:11-25.
47. Ries L, Harkins D, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2003. Bethesda, MD: National Cancer Institute; 2006.
48. James TM, Greiner KA, Ellerbeck EF, et al. Disparities in colorectal cancer screening: a guideline-based analysis of adherence. Ethn Dis 2006;16:228-233.
49. Chen JY, Diamant A, Pourat N, Kagawa-Singer M. Racial/ethnic disparities in the use of preventive services among the elderly. Am J Prev Med 2005;29:388-395.
50. Rakowski W, Meissner H, Vernon SW, et al. Correlates of repeat and recent mammography for women ages 45 to 75 in the 2002 to 2003 Health Information National Trends Survey (HINTS 2003). Cancer Epidemiol Biomarkers Prev 2006;15:2093-2101.
51. Liang SY, Phillips KA, Nagamine M, et al. Rates and predictors of colorectal cancer screening. Prev Chronic Dis 2006;3:A117.
52. Busch SH, Duchovny N. Family coverage expansions: impact on insurance coverage and health care utilization of parents. J Health Econ 2005;24:876-890.
53. Institute of Medicine. Coverage Matters: Insurance and Health Care. Washington, DC: National Academy Press; 2001.
54. DeNavas-Walt C, Proctor BD, Lee CH. Income, Poverty, and Health Insurance Coverage in the United States: 2004. Washington, DC: U.S. Government Printing Office; 2005.
55. Carney PA, Goodrich ME, Mackenzie T, et al. Utilization of screening mammography in New Hampshire. Cancer 2005;104:1726-1732.
56. Ruffin MT, Gorenflo DW, Woodman B. Predictors of screening for breast, cervical, colorectal, and prostatic cancer among community-based primary care practices. J Am Board Fam Pract 2000;13:1-10.
57. Spitzer WO, Brown BP. Unanswered questions about the periodic health examination. Ann Intern Med 1975;83:257-263.
58. Canadian Task Force on the Periodic Health Examination. The periodic health examination. CMAJ 1979;121:1193-1254.
59. Maciosek MV, Edwards NM, Coffield AB, et al. Priorities among effective clinical preventive services: methods. Am J Prev Med 2006;31:90-96.
60. Boulware LE, Barnes GJ, Wilson RF, et al. Value of the Periodic Health Evaluation. Evidence Report/Technology Assessment No. 136. (Prepared by The Johns Hopkins University Evidence-based Practice Center under Contract No. 290-02-0018). AHRQ Publication No. 06-E011. Rockville, MD: Agency for Healthcare Research and Quality; 2006.
61. U.S. Department of Health and Human Services. Healthy People 2010. 2nd ed. With Understanding and Improving Health and Objectives for Improving Health. 2 vols. Washington, DC: U.S. Government Printing Office; 2000.